|
Micro-randomized trial of a physical activity intervention to manage pain symptoms among older cancer survivors |
1K01CA255414-01A1 |
|
NCI |
2022 |
|
Biomarkers for Detection and Prediction of Chemotherapy-Related Cognitive Impairment |
3P30CA014520-48S5 |
|
NCI |
2022 |
|
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects |
3R01CA248103-02S1 |
|
NCI |
2022 |
|
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects |
3R01CA248103-02S2 |
|
NCI |
2022 |
|
Integrative Molecular Epidemiology of Neurocognitive Outcomes in Acute Lymphoblastic Leukemia |
5K07CA218362-05 |
|
NCI |
2022 |
|
Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors |
5R01CA172145-08 |
|
NCI |
2022 |
|
Predicting Long-Term Chemotherapy-Related Cognitive Impairment |
5R01CA226080-04 |
|
NCI |
2022 |
|
A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial |
5R01CA237892-03 |
|
NCI |
2022 |
|
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects |
5R01CA248103-02 |
|
NCI |
2022 |
|
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy. |
5R01CA249988-02 |
|
NCI |
2022 |